publicationMetadata:
  pmid: "36730269"
  title: "Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas."
  queryType: "bench"
  publicationType: "Lab Research"
  publicationTypeConfidence: 1.0
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    This is a laboratory research study focused on drug screening using cell lines and spheroid assays.
    Expected tool types include:
    - Cell lines (both human patient-derived and mouse glioma cell lines)
    - Antibodies (for western blot characterization and target validation)
    - Animal models (genetically engineered mouse model for cell line derivation)
    - Computational tools (analysis software for drug screening data)
    - Advanced cellular models (3D spheroid culture systems)
    
    The publication has extensive Methods section describing experimental procedures, cell culture,
    drug screening assays, and molecular characterization techniques.
  overallAssessment: |
    This is a clear laboratory research publication with extensive experimental methods describing
    drug combination screening in NF1-associated high grade gliomas. The study uses multiple cell
    lines, antibodies for protein analysis, genetically engineered mouse models, and computational
    tools for data analysis. The presence of detailed Methods section with specific protocols,
    catalog numbers, and experimental procedures strongly indicates genuine research tool usage.

toolValidations: []

potentiallyMissedTools:
  - toolName: "TM-31"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "The NF1 patient-derived HGG cell line TM-31 (RRID:CVCL_6735) [17], purchased from the RIKEN biorepository, is null for NF1, TP53, CDKN2A and ATRX."
    whyMissed: "Patient-derived cell line with RRID identifier, clearly a research tool"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "LN319"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "The Glioblastoma Multiphorme (GBM) LN319 cell line was a gift from Dr. Karen Cichowski. LN319 is an adult sporadic GBM with full inactivation of NF1."
    whyMissed: "Established GBM cell line used in experiments"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "17"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "Mouse NF1-HGG cell lines 17, 5653, and 5746 were derived from three distinct high-grade murine brain tumors sporadically developed by the NPcis genetically engineered mouse model."
    whyMissed: "Mouse glioma cell line derived from genetically engineered model"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "5653"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "Mouse NF1-HGG cell lines 17, 5653, and 5746 were derived from three distinct high-grade murine brain tumors sporadically developed by the NPcis genetically engineered mouse model."
    whyMissed: "Mouse glioma cell line derived from genetically engineered model"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "5746"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "Mouse NF1-HGG cell lines 17, 5653, and 5746 were derived from three distinct high-grade murine brain tumors sporadically developed by the NPcis genetically engineered mouse model."
    whyMissed: "Mouse glioma cell line derived from genetically engineered model"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "NPcis genetically engineered mouse model"
    toolType: "animal_model"
    foundIn: "methods"
    contextSnippet: "Mouse NF1-HGG cell lines 17, 5653, and 5746 were derived from three distinct high-grade murine brain tumors sporadically developed by the NPcis genetically engineered mouse model. The germline of these mice is heterozygous for Nf1 and Tp53; mutant alleles are located in cis."
    whyMissed: "Genetically engineered mouse model with specific genetic modifications"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "pERK antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: pERK (Catalogue # 4370)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "total ERK antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: total ERK (Catalogue # 9102)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "pAKT antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: pAKT (Catalogue # 4060)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "total AKT antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: total AKT (Catalogue # 4691)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Ubiquitin antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: Ubiquitin (Catalogue # 4289)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "MYC antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: MYC (Catalogue # 18583)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "pCHEK1 S296 antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: pCHEK1 S296 (Catalogue # 90178)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "BMI1 antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: BMI1 (Catalogue # 5856)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "H3K27Ac antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: H3K27Ac (Catalogue # 8173)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "total H3 antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: total H3 (Catalogue # 14269)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "CDK9 antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: CDK9 (Catalogue # 2316)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Vinculin antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The following antibodies were purchased from Cell signaling Technologies: Vinculin (Catalogue # 4650)"
    whyMissed: "Antibody with specific catalog number from Cell Signaling Technologies"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Beta-Actin antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "Beta-Actin (Catalogue # NB600-501) was purchased from Novus"
    whyMissed: "Antibody with specific catalog number from Novus"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "pS2 RNApol II antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "pS2 RNApol II (Catalogue # 04-1571-1) from EMD Millipore"
    whyMissed: "Antibody with specific catalog number from EMD Millipore"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "SOX2 antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "SOX2 (Catalogue # MAB2018) from R&D systems"
    whyMissed: "Antibody with specific catalog number from R&D Systems"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "NG2 antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "NG2 (Catalogue # PA5-17199) from Invitrogen"
    whyMissed: "Antibody with specific catalog number from Invitrogen"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Incucyte S3 Live-Cell Analysis System"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "The total integrated intensity of RFP was monitored over the course of 72 hours, taking measurements every 2 hours with the Incucyte® S3 Live-Cell Analysis System (Sartorius, Gottingen, Germany)"
    whyMissed: "Live-cell imaging and analysis system used for drug screening"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "GraphPad Prism 9"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "IC50 and Lethal Dose 50 (LD50) values and 95% confidence intervals were calculated to assess drug sensitivity (GraphPad Prism 9 software)"
    whyMissed: "Statistical analysis software with version number"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "SynergyFinder"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "We used the percent viability compared to untreated cells to calculate a synergy score for each of the analyzed combinations (https://synergyfinder.fimm.fi/; parameters: LL4 curve fit, ZIP method for synergy score calculation)"
    whyMissed: "Web-based tool for drug synergy analysis with specific URL"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Incucyte Nuclight Red Lentivirus"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Cell lines were transduced with Incucyte® Nuclight Red Lentivirus (Sartorius, Gottingen, Germany) such that they will produce an EF1α promoter driven nuclear restricted red fluorescent label"
    whyMissed: "Lentiviral vector for cell labeling with specific promoter"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "3D spheroid culture system"
    toolType: "advanced_cellular_model"
    foundIn: "methods"
    contextSnippet: "We evaluated drug sensitivities of the three murine glioma cell lines in a 3D spheroid growth assay, which more accurately reflects drug sensitivities in vivo."
    whyMissed: "3D spheroid culture system for drug screening"
    confidence: 1.0
    shouldBeAdded: Yes

suggestedPatterns:
  - patternType: "context_phrase"
    pattern: "antibodies were purchased from"
    toolType: "antibody"
    examples: ["The following antibodies were purchased from Cell signaling Technologies"]
    reasoning: "This phrase reliably indicates antibody procurement and usage in experimental context"

  - patternType: "naming_convention"
    pattern: "\\b[A-Z0-9]+\\s+cell line\\b"
    toolType: "cell_line"
    examples: ["TM-31 cell line", "LN319 cell line"]
    reasoning: "Standard cell line naming convention with 'cell line' descriptor"

  - patternType: "vendor_indicator"
    pattern: "\\(Catalogue #\\s*[A-Z0-9-]+\\)"
    toolType: "general"
    examples: ["(Catalogue # 4370)", "(Catalogue # NB600-501)"]
    reasoning: "Catalog numbers in parentheses strongly indicate commercial research reagents"

  - patternType: "term"
    pattern: "RRID:[A-Z]+_[0-9]+"
    toolType: "general"
    examples: ["RRID:CVCL_6735"]
    reasoning: "Research Resource Identifiers (RRIDs) are standardized identifiers for research tools"

  - patternType: "context_phrase"
    pattern: "genetically engineered mouse model"
    toolType: "animal_model"
    examples: ["NPcis genetically engineered mouse model"]
    reasoning: "Specific phrase indicating genetically modified animal models used in research"

  - patternType: "context_phrase"
    pattern: "3D spheroid.*assay"
    toolType: "advanced_cellular_model"
    examples: ["3D spheroid growth assay"]
    reasoning: "Indicates 3D culture systems which are advanced cellular models"

  - patternType: "naming_convention"
    pattern: "\\bhttps?://[\\w.-]+\\.[a-z]{2,}/?[\\w.-]*/?\\b"
    toolType: "computational_tool"
    examples: ["https://synergyfinder.fimm.fi/"]
    reasoning: "URLs often indicate web-based computational tools or databases"

  - patternType: "context_phrase"
    pattern: "derived from.*tumors.*developed by"
    toolType: "cell_line"
    examples: ["derived from three distinct high-grade murine brain tumors sporadically developed by the NPcis genetically engineered mouse model"]
    reasoning: "Indicates cell lines derived from animal models, which are research tools"

observations: []

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 24
  newPatternsCount: 8
  observationsExtracted: 0
  observationsByType: {}
  majorIssuesFound: |
    - CRITICAL: No tools were mined from this publication despite it being a clear laboratory research study
    - The publication contains extensive experimental methods with detailed protocols
    - Multiple cell lines (5), numerous antibodies (16), animal models (1), computational tools (3), genetic reagents (1), and advanced cellular models (1) were completely missed
    - All tools have clear experimental context with catalog numbers, vendor information, and usage descriptions
    - This represents a major failure of the mining system for this publication type
  recommendations: |
    - ALL 24 identified tools should be added to the database - they represent genuine research tools with clear experimental usage
    - The mining patterns need significant improvement to catch:
      * Cell lines with standard naming conventions
      * Antibodies listed with catalog numbers and vendors
      * Genetically engineered mouse models
      * Computational analysis software
      * 3D culture systems and spheroid assays
      * Lentiviral vectors and genetic reagents
    - Implement the 8 suggested patterns to improve future mining accuracy
    - This publication should be re-processed with improved mining algorithms
    - Consider manual curation for similar high-quality laboratory research publications
    - No observations were extracted since no tools were initially mined, but the Results section likely contains valuable phenotypic and efficacy data for the identified tools
